Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03394456 · ClinicalTrials.gov registry record · NA

Technology to Improve the Health of Resource-poor Hispanics With Diabetes

A NA study of Diabetes Mellitus, Type 2, sponsored by Baylor College of Medicine.

Completed
Registry status
NA
Development phase
265
Enrollment target
1
Study location

NCT03394456 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by Baylor College of Medicine. The registered enrollment target is 265 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03394456, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
NA
Development phase
265 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the efficacy and implementation of a telehealth-supported, integrated diabetes group visit program led by Community Health Workers (CHWs). Primary study relates to efficacy and a secondary study addresses mentored implementation.

Conditions Studied

Interventions

  • OTHER diabetes program
  • OTHER telehealth training and support for Community Health Workers

Study Locations (1)

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 265 participants
Start Date 2018-01-13
Est. Completion 2022-08-30
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT03394456

The ClinicalTrials.gov registry entry for NCT03394456 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (94% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which diabetes program is the first listed.

NCT03394456 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03394456 about?

NCT03394456 is a clinical study titled "Technology to Improve the Health of Resource-poor Hispanics With Diabetes". This study evaluates the efficacy and implementation of a telehealth-supported, integrated diabetes group visit program led by Community Health Workers (CHWs). Primary study relates to efficacy and a secondary study addresses mentored implementation.

What is the current status of trial NCT03394456?

This trial is currently completed. It is a NA study. The enrollment target is 265 participants. The study started on 2018-01-13. Estimated completion is 2022-08-30.

What conditions does trial NCT03394456 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT03394456?

The interventions under investigation include: diabetes program (OTHER), telehealth training and support for Community Health Workers (OTHER).

Who is sponsoring clinical trial NCT03394456?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03394456 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.